Stellaromics Inc

Stellaromics Inc. is a biotechnology company headquartered in Boston, Massachusetts. Founded in 2022, the company employs 30 individuals. Stellaromics specializes in developing innovative technologies for biomedical research. Their flagship product, STARmap (Spatially-resolved Transcript Amplicon Readout mapping), allows researchers to analyze gene expression patterns within living tissue, aiding in the identification of potential treatment targets and advancing biomedical studies. The company is also developing its Plexa™ suite of products, designed to help create detailed cellular maps and further our understanding of various diseases. Stellaromics distinguishes itself through its proprietary technology and focus on spatially-resolved transcriptomics. Their tools empower researchers to gain a deeper understanding of complex biological processes within native tissue, leading to more precise and effective research outcomes. For more information about Stellaromics Inc. and its products, please visit their website at stellaromics.com.